SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3g1u'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4G_B_ZMRB466_2
(NEURAMINIDASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		3 / 3 ASP A 302
ARG A 342
ILE A  78
 None
 0.88A 1a4gB-3g1uA:
undetectable		 1a4gB-3g1uA:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CRB_A_RTLA200_0
(CELLULAR RETINOL
BINDING PROTEIN)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 LEU A  67
LEU A  64
LEU A  29
LYS A 398
ILE A 369
 None
 0.95A 1crbA-3g1uA:
undetectable		 1crbA-3g1uA:
15.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4F_A_ADNA601_1
(S-ADENOSYLHOMOCYSTEI
NE HYDROLASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		9 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
LEU A 343
LEU A 346
GLY A 351
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.67A 1d4fA-3g1uA:
59.7		 1d4fA-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4F_A_ADNA601_2
(S-ADENOSYLHOMOCYSTEI
NE HYDROLASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 THR A  57
GLU A 155
THR A 156
HIS A 300
HIS A 352
 ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 3.6A)
 0.64A 1d4fA-3g1uA:
59.7		 1d4fA-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4F_B_ADNB602_1
(S-ADENOSYLHOMOCYSTEI
NE HYDROLASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		9 / 12 LEU A  51
HIS A  52
ASP A 130
HIS A 300
LEU A 343
LEU A 346
GLY A 351
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.71A 1d4fB-3g1uA:
59.8		 1d4fB-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4F_B_ADNB602_2
(S-ADENOSYLHOMOCYSTEI
NE HYDROLASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 THR A  54
THR A  57
GLU A 155
THR A 156
HIS A 352
 ADN  A 438 (-2.8A)
ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 3.6A)
 0.59A 1d4fB-3g1uA:
59.8		 1d4fB-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4F_C_ADNC603_1
(S-ADENOSYLHOMOCYSTEI
NE HYDROLASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		9 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
LEU A 343
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.68A 1d4fC-3g1uA:
59.7		 1d4fC-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4F_C_ADNC603_2
(S-ADENOSYLHOMOCYSTEI
NE HYDROLASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 THR A  57
GLU A 155
THR A 156
HIS A 300
LEU A 346
 ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
 0.64A 1d4fC-3g1uA:
59.7		 1d4fC-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4F_D_ADND604_1
(S-ADENOSYLHOMOCYSTEI
NE HYDROLASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		9 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
LEU A 343
LEU A 346
GLY A 351
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.68A 1d4fD-3g1uA:
59.6		 1d4fD-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4F_D_ADND604_2
(S-ADENOSYLHOMOCYSTEI
NE HYDROLASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 THR A  57
GLU A 155
THR A 156
HIS A 300
HIS A 352
 ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 3.6A)
 0.67A 1d4fD-3g1uA:
59.6		 1d4fD-3g1uA:
71.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DHF_B_FOLB187_0
(DIHYDROFOLATE
REDUCTASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 ILE A 294
THR A 273
ILE A 298
ASN A 345
LEU A 198
 None
None
NAD  A 439 (-4.6A)
NAD  A 439 (-3.1A)
None
 1.14A 1dhfB-3g1uA:
undetectable		 1dhfB-3g1uA:
17.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HK1_A_T44A3003_1
(SERUM ALBUMIN)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 6 HIS A 269
ILE A 270
ALA A 230
VAL A 272
 None
 1.03A 1hk1A-3g1uA:
undetectable		 1hk1A-3g1uA:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HRK_A_CHDA1503_0
(FERROCHELATASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		3 / 3 LEU A 391
PRO A 392
LEU A 395
 None
 0.55A 1hrkA-3g1uA:
4.3		 1hrkA-3g1uA:
21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KIJ_A_NOVA400_1
(DNA GYRASE SUBUNIT B)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 ASP A 129
ARG A 166
ILE A 174
PRO A 173
ILE A 149
 None
 1.32A 1kijA-3g1uA:
undetectable		 1kijA-3g1uA:
23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MUI_B_AB1B100_1
(PROTEASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 10 GLY A 383
ALA A 386
VAL A 388
GLY A 151
ILE A 149
 None
 0.98A 1muiA-3g1uA:
undetectable		 1muiA-3g1uA:
14.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SH9_B_RITB301_2
(POL POLYPROTEIN)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 10 ASP A 129
GLY A 132
ILE A 174
PRO A 124
ALA A  48
 None
 1.07A 1sh9B-3g1uA:
undetectable		 1sh9B-3g1uA:
13.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1V8B_A_ADNA502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 LEU A  51
ASP A 130
THR A 156
LEU A 343
HIS A 352
 None
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.6A)
 1.48A 1v8bA-3g1uA:
55.2		 1v8bA-3g1uA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1V8B_A_ADNA502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
THR A 156
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.54A 1v8bA-3g1uA:
55.2		 1v8bA-3g1uA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1V8B_B_ADNB1502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
THR A 156
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.54A 1v8bB-3g1uA:
55.0		 1v8bB-3g1uA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1V8B_C_ADNC2502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		9 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.55A 1v8bC-3g1uA:
55.2		 1v8bC-3g1uA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1V8B_D_ADND3502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
THR A 156
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.55A 1v8bD-3g1uA:
52.9		 1v8bD-3g1uA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_A_ADNA433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		6 / 12 HIS A  52
HIS A 300
LEU A 346
GLY A 351
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 1.00A 1xwfA-3g1uA:
54.2		 1xwfA-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_A_ADNA433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		6 / 12 HIS A  52
THR A  54
HIS A 300
GLY A 351
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.94A 1xwfA-3g1uA:
54.2		 1xwfA-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_A_ADNA433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A 300
LEU A 343
LEU A 346
GLY A 351
MET A 357
 ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
 0.76A 1xwfA-3g1uA:
54.2		 1xwfA-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_A_ADNA433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 LEU A  51
HIS A  52
ASP A 130
LEU A 343
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 4.0A)
None
 1.22A 1xwfA-3g1uA:
54.2		 1xwfA-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_A_ADNA433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		7 / 12 LEU A  51
HIS A  52
ASP A 130
LEU A 346
GLY A 351
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.89A 1xwfA-3g1uA:
54.2		 1xwfA-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_A_ADNA433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		7 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLY A 351
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.68A 1xwfA-3g1uA:
54.2		 1xwfA-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_B_ADNB433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		6 / 12 HIS A  52
HIS A 300
LEU A 346
GLY A 351
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.98A 1xwfB-3g1uA:
54.2		 1xwfB-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_B_ADNB433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		6 / 12 HIS A  52
THR A  54
HIS A 300
GLY A 351
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.90A 1xwfB-3g1uA:
54.2		 1xwfB-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_B_ADNB433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A 300
LEU A 343
LEU A 346
GLY A 351
MET A 357
 ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
 0.76A 1xwfB-3g1uA:
54.2		 1xwfB-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_B_ADNB433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 LEU A  51
HIS A  52
ASP A 130
LEU A 343
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 4.0A)
None
 1.20A 1xwfB-3g1uA:
54.2		 1xwfB-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_B_ADNB433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		7 / 12 LEU A  51
HIS A  52
ASP A 130
LEU A 346
GLY A 351
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.92A 1xwfB-3g1uA:
54.2		 1xwfB-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_B_ADNB433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		7 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLY A 351
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.68A 1xwfB-3g1uA:
54.2		 1xwfB-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_C_ADNC433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		6 / 12 HIS A  52
HIS A 300
LEU A 346
GLY A 351
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 1.02A 1xwfC-3g1uA:
54.0		 1xwfC-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_C_ADNC433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		6 / 12 HIS A  52
THR A  54
HIS A 300
GLY A 351
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.95A 1xwfC-3g1uA:
54.0		 1xwfC-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_C_ADNC433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A 300
LEU A 343
LEU A 346
GLY A 351
MET A 357
 ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
 0.78A 1xwfC-3g1uA:
54.0		 1xwfC-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_C_ADNC433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 LEU A  51
HIS A  52
ASP A 130
LEU A 343
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 4.0A)
None
 1.20A 1xwfC-3g1uA:
54.0		 1xwfC-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_C_ADNC433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		7 / 12 LEU A  51
HIS A  52
ASP A 130
LEU A 346
GLY A 351
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.92A 1xwfC-3g1uA:
54.0		 1xwfC-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_C_ADNC433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		7 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLY A 351
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.70A 1xwfC-3g1uA:
54.0		 1xwfC-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_D_ADND433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		6 / 12 HIS A  52
HIS A 300
LEU A 346
GLY A 351
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 1.04A 1xwfD-3g1uA:
54.0		 1xwfD-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_D_ADND433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		6 / 12 HIS A  52
THR A  54
HIS A 300
GLY A 351
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.96A 1xwfD-3g1uA:
54.0		 1xwfD-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_D_ADND433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A 300
LEU A 343
LEU A 346
GLY A 351
MET A 357
 ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
 0.80A 1xwfD-3g1uA:
54.0		 1xwfD-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_D_ADND433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 LEU A  51
HIS A  52
ASP A 130
LEU A 343
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 4.0A)
None
 1.19A 1xwfD-3g1uA:
54.0		 1xwfD-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_D_ADND433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		7 / 12 LEU A  51
HIS A  52
ASP A 130
LEU A 346
GLY A 351
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.96A 1xwfD-3g1uA:
54.0		 1xwfD-3g1uA:
71.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XWF_D_ADND433_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		7 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLY A 351
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 3.8A)
ADN  A 438 (-3.7A)
None
 0.71A 1xwfD-3g1uA:
54.0		 1xwfD-3g1uA:
71.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XZX_X_T3X500_2
(THYROID HORMONE
RECEPTOR BETA-1)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		3 / 3 PHE A 389
ARG A 375
ASN A 374
 None
 0.91A 1xzxX-3g1uA:
undetectable		 1xzxX-3g1uA:
21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CP4_A_CAMA416_0
(CYTOCHROME P450-CAM)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 10 THR A 274
LEU A 191
GLY A 226
VAL A 240
VAL A 217
 None
 1.25A 2cp4A-3g1uA:
undetectable		 2cp4A-3g1uA:
21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HS2_B_017B203_1
(PROTEASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 6 PRO A 147
LEU A 145
ARG A 382
GLY A 151
 None
 1.15A 2hs2B-3g1uA:
undetectable		 2hs2B-3g1uA:
14.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QD5_B_CHDB1104_0
(FERROCHELATASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		3 / 3 LEU A 391
PRO A 392
LEU A 395
 None
 0.44A 2qd5B-3g1uA:
4.2		 2qd5B-3g1uA:
21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7W_C_SALC1300_1
(LYSR-TYPE REGULATORY
PROTEIN)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 7 THR A 274
ILE A 298
GLY A 299
HIS A 352
 None
NAD  A 439 (-4.6A)
NAD  A 439 (-3.4A)
ADN  A 438 ( 3.6A)
 0.84A 2y7wC-3g1uA:
undetectable		 2y7wC-3g1uA:
18.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ZJ0_A_2FAA500_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.71A 2zj0A-3g1uA:
53.4		 2zj0A-3g1uA:
54.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ZJ0_A_2FAA500_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 GLN A  56
THR A  57
THR A 156
HIS A 300
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
 0.33A 2zj0A-3g1uA:
53.4		 2zj0A-3g1uA:
54.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 343
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.66A 2zj0B-3g1uA:
53.5		 2zj0B-3g1uA:
54.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ZJ0_B_2FAB500_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 LEU A  51
GLN A  56
THR A  57
THR A 156
HIS A 300
 None
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
 0.34A 2zj0B-3g1uA:
53.5		 2zj0B-3g1uA:
54.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ZJ0_C_2FAC500_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 343
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.69A 2zj0C-3g1uA:
53.4		 2zj0C-3g1uA:
54.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ZJ0_C_2FAC500_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
LEU A 343
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 4.0A)
ADN  A 438 (-3.7A)
 1.48A 2zj0C-3g1uA:
53.4		 2zj0C-3g1uA:
54.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 LEU A  51
GLN A  56
THR A  57
THR A 156
HIS A 300
 None
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
 0.28A 2zj0C-3g1uA:
53.4		 2zj0C-3g1uA:
54.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ZJ0_D_2FAD500_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
HIS A 300
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.66A 2zj0D-3g1uA:
53.8		 2zj0D-3g1uA:
54.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ZJ0_D_2FAD500_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 LEU A  51
GLN A  56
THR A  57
THR A 156
 None
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
 0.19A 2zj0D-3g1uA:
53.8		 2zj0D-3g1uA:
54.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B9L_A_AZZA1009_1
(SERUM ALBUMIN)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 8 GLU A 155
SER A 360
GLN A 364
VAL A 388
 ADN  A 438 (-3.8A)
ADN  A 438 ( 4.6A)
None
None
 1.12A 3b9lA-3g1uA:
undetectable		 3b9lA-3g1uA:
22.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CE6_A_ADNA500_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.69A 3ce6A-3g1uA:
55.4		 3ce6A-3g1uA:
54.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CE6_A_ADNA500_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 GLN A  56
THR A  57
THR A 156
HIS A 300
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
 0.19A 3ce6A-3g1uA:
55.4		 3ce6A-3g1uA:
54.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CE6_B_ADNB500_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 343
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.70A 3ce6B-3g1uA:
54.0		 3ce6B-3g1uA:
54.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CE6_B_ADNB500_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 LEU A  51
GLN A  56
THR A  57
THR A 156
HIS A 300
 None
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
 0.19A 3ce6B-3g1uA:
54.0		 3ce6B-3g1uA:
54.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CE6_C_ADNC500_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.69A 3ce6C-3g1uA:
54.0		 3ce6C-3g1uA:
54.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CE6_C_ADNC500_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 GLN A  56
THR A  57
THR A 156
HIS A 300
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
 0.24A 3ce6C-3g1uA:
54.0		 3ce6C-3g1uA:
54.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CE6_D_ADND500_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
THR A 156
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.70A 3ce6D-3g1uA:
54.0		 3ce6D-3g1uA:
54.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CE6_D_ADND500_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
THR A 156
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
ADN  A 438 (-3.7A)
 1.44A 3ce6D-3g1uA:
54.0		 3ce6D-3g1uA:
54.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CE6_D_ADND500_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 LEU A  51
GLN A  56
THR A  57
HIS A 300
LEU A 343
 None
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
 0.22A 3ce6D-3g1uA:
54.0		 3ce6D-3g1uA:
54.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ELZ_B_CHDB200_0
(ILEAL BILE
ACID-BINDING PROTEIN)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 5 PRO A 353
VAL A 356
THR A 274
GLY A 224
 None
 0.94A 3elzB-3g1uA:
undetectable		 3elzB-3g1uA:
15.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GLQ_A_RABA602_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
LEU A 343
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.51A 3glqA-3g1uA:
55.6		 3glqA-3g1uA:
55.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GLQ_A_RABA602_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 GLN A  56
THR A  57
GLU A 155
THR A 156
HIS A 300
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
 0.46A 3glqA-3g1uA:
55.6		 3glqA-3g1uA:
55.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GLQ_B_RABB602_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
LEU A 343
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.52A 3glqB-3g1uA:
55.6		 3glqB-3g1uA:
55.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GLQ_B_RABB602_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 GLN A  56
THR A  57
GLU A 155
THR A 156
HIS A 300
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
 0.19A 3glqB-3g1uA:
55.6		 3glqB-3g1uA:
55.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H9U_A_ADNA439_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 10 LEU A  51
HIS A  52
THR A  54
GLN A  56
THR A  57
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.19A 3h9uA-3g1uA:
62.4		 3h9uA-3g1uA:
85.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H9U_B_ADNB438_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 10 HIS A  52
THR A  54
GLN A  56
THR A  57
ASN A 345
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 (-3.1A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.21A 3h9uB-3g1uA:
62.6		 3h9uB-3g1uA:
85.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H9U_C_ADNC438_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 10 LEU A  51
HIS A  52
THR A  54
GLN A  56
THR A  57
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.17A 3h9uC-3g1uA:
63.1		 3h9uC-3g1uA:
85.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H9U_D_ADND438_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 10 LEU A  51
HIS A  52
THR A  54
GLN A  56
THR A  57
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.17A 3h9uD-3g1uA:
63.3		 3h9uD-3g1uA:
85.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KPB_A_SAMA1000_0
(UNCHARACTERIZED
PROTEIN MJ0100)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		6 / 12 ASN A 162
ILE A 139
VAL A 146
ILE A 149
ILE A 127
PRO A 173
 None
 1.22A 3kpbA-3g1uA:
undetectable		 3kpbA-3g1uA:
16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KPB_C_SAMC1000_0
(UNCHARACTERIZED
PROTEIN MJ0100)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 ILE A 139
VAL A 146
ILE A 149
ILE A 127
PRO A 173
 None
 1.20A 3kpbC-3g1uA:
undetectable		 3kpbC-3g1uA:
16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KPC_A_SAMA1000_0
(UNCHARACTERIZED
PROTEIN MJ0100)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 11 ILE A 139
VAL A 146
ILE A 149
ILE A 127
PRO A 173
 None
 1.27A 3kpcA-3g1uA:
undetectable		 3kpcA-3g1uA:
16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LXI_A_CAMA423_0
(CYTOCHROME P450)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 10 THR A 274
LEU A 191
GLY A 226
VAL A 240
VAL A 217
 None
 1.29A 3lxiA-3g1uA:
undetectable		 3lxiA-3g1uA:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LXI_B_CAMB423_0
(CYTOCHROME P450)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 11 THR A 274
LEU A 191
GLY A 226
VAL A 240
VAL A 217
 None
 1.26A 3lxiB-3g1uA:
undetectable		 3lxiB-3g1uA:
22.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3N58_A_ADNA500_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
LEU A 343
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.50A 3n58A-3g1uA:
55.8		 3n58A-3g1uA:
58.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3N58_A_ADNA500_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 GLN A  56
THR A  57
GLU A 155
THR A 156
HIS A 300
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
 0.18A 3n58A-3g1uA:
55.8		 3n58A-3g1uA:
58.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3N58_C_ADNC500_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
THR A 156
LEU A 343
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.50A 3n58C-3g1uA:
55.9		 3n58C-3g1uA:
58.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3N58_C_ADNC500_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 LEU A  51
GLN A  56
THR A  57
GLU A 155
HIS A 300
 None
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.0A)
 0.20A 3n58C-3g1uA:
55.9		 3n58C-3g1uA:
58.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3N58_D_ADND500_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
THR A 156
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
ADN  A 438 (-3.7A)
 1.49A 3n58D-3g1uA:
58.3		 3n58D-3g1uA:
58.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3N58_D_ADND500_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
THR A 156
LEU A 343
LEU A 346
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.52A 3n58D-3g1uA:
58.3		 3n58D-3g1uA:
58.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3N58_D_ADND500_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 GLN A  56
THR A  57
GLU A 155
HIS A 300
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.0A)
 0.19A 3n58D-3g1uA:
58.3		 3n58D-3g1uA:
58.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OND_A_ADNA506_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 ASP A 130
GLU A 155
THR A 156
LEU A 343
HIS A 352
 ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.6A)
 1.39A 3ondA-3g1uA:
59.8		 3ondA-3g1uA:
58.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OND_A_ADNA506_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
THR A 156
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.48A 3ondA-3g1uA:
59.8		 3ondA-3g1uA:
58.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OND_A_ADNA506_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
THR A 156
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
ADN  A 438 (-3.7A)
 1.48A 3ondA-3g1uA:
59.8		 3ondA-3g1uA:
58.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OND_A_ADNA506_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		3 / 3 GLN A  56
THR A  57
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 4.0A)
 0.68A 3ondA-3g1uA:
59.8		 3ondA-3g1uA:
58.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OND_B_ADNB507_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 ASP A 130
GLU A 155
THR A 156
LEU A 343
HIS A 352
 ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.6A)
 1.41A 3ondB-3g1uA:
52.8		 3ondB-3g1uA:
58.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OND_B_ADNB507_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
THR A 156
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.49A 3ondB-3g1uA:
52.8		 3ondB-3g1uA:
58.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OND_B_ADNB507_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
THR A 156
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
ADN  A 438 (-3.7A)
 1.48A 3ondB-3g1uA:
52.8		 3ondB-3g1uA:
58.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OND_B_ADNB507_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		3 / 3 GLN A  56
THR A  57
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 4.0A)
 0.70A 3ondB-3g1uA:
52.8		 3ondB-3g1uA:
58.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RLB_B_VIBB187_1
(THIT)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 ILE A 177
GLU A 370
TYR A 380
TYR A 164
VAL A 388
 None
 1.25A 3rlbB-3g1uA:
undetectable		 3rlbB-3g1uA:
17.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T7V_A_SAMA992_0
(METHYLORNITHINE
SYNTHASE PYLB)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 GLY A  28
TYR A  36
LEU A  42
GLN A 364
ALA A 367
 None
 1.16A 3t7vA-3g1uA:
undetectable		 3t7vA-3g1uA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W1W_B_CHDB503_0
(FERROCHELATASE,
MITOCHONDRIAL)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		3 / 3 LEU A 391
PRO A 392
LEU A 395
 None
 0.46A 3w1wB-3g1uA:
4.4		 3w1wB-3g1uA:
21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ACB_B_DXCB1473_0
(TRANSLATION
ELONGATION FACTOR
SELB)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 8 ILE A 149
GLY A 151
VAL A 115
SER A  74
 None
 0.79A 4acbB-3g1uA:
3.0
4acbC-3g1uA:
4.8		 4acbB-3g1uA:
22.86
4acbC-3g1uA:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C9K_B_CAMB424_0
(CYTOCHROME P450)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 9 THR A 274
LEU A 191
GLY A 226
VAL A 240
VAL A 217
 None
 1.34A 4c9kB-3g1uA:
undetectable		 4c9kB-3g1uA:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C9N_B_CAMB1420_0
(CYTOCHROME P450)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 10 THR A 274
LEU A 191
GLY A 226
VAL A 240
VAL A 217
 None
 1.35A 4c9nB-3g1uA:
undetectable		 4c9nB-3g1uA:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C9P_A_CAMA423_0
(CYTOCHROME P450)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 9 THR A 274
LEU A 191
GLY A 226
VAL A 240
VAL A 217
 None
 1.29A 4c9pA-3g1uA:
undetectable		 4c9pA-3g1uA:
22.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C9P_B_CAMB423_0
(CYTOCHROME P450)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 10 THR A 274
LEU A 191
GLY A 226
VAL A 240
VAL A 217
 None
 1.25A 4c9pB-3g1uA:
undetectable		 4c9pB-3g1uA:
22.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4COX_A_IMNA701_1
(CYCLOOXYGENASE-2)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 VAL A 272
LEU A 191
GLY A 226
ALA A 228
LEU A 231
 None
 1.12A 4coxA-3g1uA:
undetectable		 4coxA-3g1uA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4COX_B_IMNB701_1
(CYCLOOXYGENASE-2)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 VAL A 272
LEU A 191
GLY A 226
ALA A 228
LEU A 231
 None
 1.11A 4coxB-3g1uA:
undetectable		 4coxB-3g1uA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4COX_D_IMND701_1
(CYCLOOXYGENASE-2)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 VAL A 272
LEU A 191
GLY A 226
ALA A 228
LEU A 231
 None
 1.11A 4coxD-3g1uA:
undetectable		 4coxD-3g1uA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DQC_A_017A101_2
(ASPARTYL PROTEASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 9 GLY A 383
ALA A 386
VAL A 388
GLY A 151
ILE A 149
 None
 1.07A 4dqcB-3g1uA:
undetectable		 4dqcB-3g1uA:
14.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBG_A_ADNA402_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 10 ALA A  98
VAL A  94
ALA A  58
ALA A  85
ILE A  89
 None
 1.07A 4lbgA-3g1uA:
4.8		 4lbgA-3g1uA:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LBG_B_ADNB402_1
(PROBABLE SUGAR
KINASE PROTEIN)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 9 ALA A  98
VAL A  94
ALA A  58
ALA A  85
ILE A  89
 None
 1.06A 4lbgB-3g1uA:
4.8		 4lbgB-3g1uA:
22.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LVC_A_ADNA501_1
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE
(SAHASE))		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.48A 4lvcA-3g1uA:
57.7		 4lvcA-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LVC_A_ADNA501_2
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE
(SAHASE))		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 GLN A  56
THR A  57
THR A 156
HIS A 300
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
 0.57A 4lvcA-3g1uA:
57.7		 4lvcA-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LVC_B_ADNB501_1
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE
(SAHASE))		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
HIS A 300
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 (-3.7A)
 1.35A 4lvcB-3g1uA:
55.7		 4lvcB-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LVC_B_ADNB501_1
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE
(SAHASE))		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
HIS A 300
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.50A 4lvcB-3g1uA:
55.7		 4lvcB-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LVC_B_ADNB501_2
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE
(SAHASE))		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 GLN A  56
THR A  57
THR A 156
LEU A 343
LEU A 346
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
 0.58A 4lvcB-3g1uA:
55.7		 4lvcB-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LVC_C_ADNC501_1
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE
(SAHASE))		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.48A 4lvcC-3g1uA:
57.3		 4lvcC-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LVC_C_ADNC501_2
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE
(SAHASE))		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 GLN A  56
THR A  57
THR A 156
HIS A 300
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
 0.58A 4lvcC-3g1uA:
57.3		 4lvcC-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PFJ_A_ADNA502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 LEU A  51
ASP A 130
GLU A 155
LEU A 343
HIS A 352
 None
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.6A)
 1.40A 4pfjA-3g1uA:
62.5		 4pfjA-3g1uA:
70.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PFJ_A_ADNA502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.49A 4pfjA-3g1uA:
62.5		 4pfjA-3g1uA:
70.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PFJ_A_ADNA502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		6 / 7 THR A  57
THR A 156
HIS A 300
LEU A 343
ASN A 345
SER A 360
 ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
NAD  A 439 (-3.1A)
ADN  A 438 ( 4.6A)
 0.65A 4pfjA-3g1uA:
62.5		 4pfjA-3g1uA:
70.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PFJ_B_ADNB502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 343
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.37A 4pfjB-3g1uA:
60.5		 4pfjB-3g1uA:
70.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PFJ_B_ADNB502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
LEU A 343
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 4.0A)
ADN  A 438 (-3.7A)
 1.47A 4pfjB-3g1uA:
60.5		 4pfjB-3g1uA:
70.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PFJ_B_ADNB502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 6 THR A  57
GLN A  82
THR A 156
HIS A 300
ASN A 345
 ADN  A 438 (-4.6A)
None
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
NAD  A 439 (-3.1A)
 0.27A 4pfjB-3g1uA:
60.5		 4pfjB-3g1uA:
70.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PGF_A_ADNA502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
ASP A 130
GLU A 155
LEU A 343
ASN A 345
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
NAD  A 439 (-3.1A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.56A 4pgfA-3g1uA:
62.1		 4pgfA-3g1uA:
70.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PGF_A_ADNA502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 6 THR A  54
THR A  57
THR A 156
HIS A 300
LEU A 346
 ADN  A 438 (-2.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
 0.20A 4pgfA-3g1uA:
62.1		 4pgfA-3g1uA:
70.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PGF_B_ADNB502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		9 / 12 HIS A  52
ASP A 130
GLU A 155
LEU A 343
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.44A 4pgfB-3g1uA:
31.3		 4pgfB-3g1uA:
70.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PGF_B_ADNB502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 THR A  54
THR A  57
THR A 156
HIS A 300
ASN A 345
 ADN  A 438 (-2.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
NAD  A 439 (-3.1A)
 0.31A 4pgfB-3g1uA:
31.3		 4pgfB-3g1uA:
70.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PGF_B_ADNB502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 5 THR A 156
THR A 157
THR A 273
ASN A 345
 NAD  A 439 ( 3.0A)
NAD  A 439 (-3.2A)
None
NAD  A 439 (-3.1A)
 1.38A 4pgfB-3g1uA:
31.3		 4pgfB-3g1uA:
70.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z69_A_DIFA1006_1
(SERUM ALBUMIN)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 7 ILE A 298
LEU A 198
GLY A 226
LYS A 225
 NAD  A 439 (-4.6A)
None
None
None
 1.00A 4z69A-3g1uA:
undetectable		 4z69A-3g1uA:
22.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AXA_A_ADNA502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 LEU A  51
ASP A 130
GLU A 155
LEU A 343
HIS A 352
 None
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.6A)
 1.35A 5axaA-3g1uA:
61.1		 5axaA-3g1uA:
72.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AXA_A_ADNA502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.49A 5axaA-3g1uA:
61.1		 5axaA-3g1uA:
72.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AXA_C_ADNC502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 LEU A  51
ASP A 130
GLU A 155
LEU A 343
HIS A 352
 None
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.6A)
 1.34A 5axaC-3g1uA:
61.0		 5axaC-3g1uA:
72.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AXA_C_ADNC502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.46A 5axaC-3g1uA:
61.0		 5axaC-3g1uA:
72.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AXD_A_RBVA502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		9 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
THR A 156
LEU A 346
GLY A 351
HIS A 352
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
 0.53A 5axdA-3g1uA:
61.1		 5axdA-3g1uA:
72.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AXD_C_RBVC502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		9 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
THR A 156
LEU A 346
GLY A 351
HIS A 352
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
 0.51A 5axdC-3g1uA:
60.9		 5axdC-3g1uA:
72.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AXD_C_RBVC502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
THR A 156
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
ADN  A 438 (-3.7A)
 1.47A 5axdC-3g1uA:
60.9		 5axdC-3g1uA:
72.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DZK_R_BEZR801_0
(ATP-DEPENDENT CLP
PROTEASE PROTEOLYTIC
SUBUNIT 2
BEZ-LEU-LEU)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 7 SER A 175
ALA A 176
PRO A 173
LEU A 167
 None
 1.10A 5dzkD-3g1uA:
1.2
5dzkR-3g1uA:
undetectable		 5dzkD-3g1uA:
18.31
5dzkR-3g1uA:
0.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_A_ADNA501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
HIS A 300
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 (-3.7A)
 1.38A 5hm8A-3g1uA:
50.9		 5hm8A-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_A_ADNA501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
HIS A 300
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.52A 5hm8A-3g1uA:
50.9		 5hm8A-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_A_ADNA501_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 5 THR A  57
GLU A 155
THR A 156
LEU A 343
 ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
 0.58A 5hm8A-3g1uA:
50.9		 5hm8A-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_B_ADNB501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
HIS A 300
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 (-3.7A)
 1.38A 5hm8B-3g1uA:
50.9		 5hm8B-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_B_ADNB501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
HIS A 300
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.52A 5hm8B-3g1uA:
50.9		 5hm8B-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_B_ADNB501_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 5 THR A  57
GLU A 155
THR A 156
LEU A 343
 ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
 0.58A 5hm8B-3g1uA:
50.9		 5hm8B-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_C_ADNC501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
HIS A 300
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 (-3.7A)
 1.38A 5hm8C-3g1uA:
51.4		 5hm8C-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_C_ADNC501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
HIS A 300
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.52A 5hm8C-3g1uA:
51.4		 5hm8C-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_C_ADNC501_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 5 THR A  57
GLU A 155
THR A 156
LEU A 343
 ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
 0.58A 5hm8C-3g1uA:
51.4		 5hm8C-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_D_ADND501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
HIS A 300
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 (-3.7A)
 1.38A 5hm8D-3g1uA:
51.0		 5hm8D-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_D_ADND501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
HIS A 300
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.52A 5hm8D-3g1uA:
51.0		 5hm8D-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_D_ADND501_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 5 THR A  57
GLU A 155
THR A 156
LEU A 343
 ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
 0.58A 5hm8D-3g1uA:
51.0		 5hm8D-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_E_ADNE501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
HIS A 300
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 (-3.7A)
 1.38A 5hm8E-3g1uA:
51.4		 5hm8E-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_E_ADNE501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
HIS A 300
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.52A 5hm8E-3g1uA:
51.4		 5hm8E-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_E_ADNE501_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 5 THR A  57
GLU A 155
THR A 156
LEU A 343
 ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
 0.58A 5hm8E-3g1uA:
51.4		 5hm8E-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_F_ADNF501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
HIS A 300
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 (-3.7A)
 1.38A 5hm8F-3g1uA:
31.1		 5hm8F-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_F_ADNF501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
HIS A 300
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.52A 5hm8F-3g1uA:
31.1		 5hm8F-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_F_ADNF501_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 5 THR A  57
GLU A 155
THR A 156
LEU A 343
 ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
 0.58A 5hm8F-3g1uA:
31.1		 5hm8F-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_G_ADNG501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
HIS A 300
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 (-3.7A)
 1.38A 5hm8G-3g1uA:
50.8		 5hm8G-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_G_ADNG501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
HIS A 300
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.52A 5hm8G-3g1uA:
50.8		 5hm8G-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_G_ADNG501_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 5 THR A  57
GLU A 155
THR A 156
LEU A 343
 ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
 0.77A 5hm8G-3g1uA:
50.8		 5hm8G-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_H_ADNH501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
HIS A 300
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 (-3.7A)
 1.38A 5hm8H-3g1uA:
51.5		 5hm8H-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_H_ADNH501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
HIS A 300
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.53A 5hm8H-3g1uA:
51.5		 5hm8H-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HM8_H_ADNH501_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 5 THR A  57
GLU A 155
THR A 156
LEU A 343
 ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
 0.58A 5hm8H-3g1uA:
51.5		 5hm8H-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5K_A_ADNA502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.51A 5m5kA-3g1uA:
57.2		 5m5kA-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5K_A_ADNA502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 GLN A  56
THR A  57
THR A 156
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
 0.64A 5m5kA-3g1uA:
57.2		 5m5kA-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5K_B_ADNB502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
THR A 156
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.59A 5m5kB-3g1uA:
57.1		 5m5kB-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5K_B_ADNB502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 GLN A  56
THR A  57
LEU A 343
LEU A 346
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
 0.60A 5m5kB-3g1uA:
57.1		 5m5kB-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5K_C_ADNC502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.50A 5m5kC-3g1uA:
54.6		 5m5kC-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5K_C_ADNC502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 GLN A  56
THR A  57
THR A 156
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
 0.64A 5m5kC-3g1uA:
54.6		 5m5kC-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M66_A_ADNA502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
THR A 156
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.52A 5m66A-3g1uA:
57.0		 5m66A-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M66_A_ADNA502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 GLN A  56
THR A  57
GLU A 155
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
 0.64A 5m66A-3g1uA:
57.0		 5m66A-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M66_B_ADNB502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.48A 5m66B-3g1uA:
56.6		 5m66B-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M66_B_ADNB502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 GLN A  56
THR A  57
THR A 156
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
 0.61A 5m66B-3g1uA:
56.6		 5m66B-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M66_C_ADNC502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
GLN A  56
ASP A 130
THR A 156
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-3.8A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.51A 5m66C-3g1uA:
56.6		 5m66C-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M66_C_ADNC502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
THR A 156
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
ADN  A 438 (-3.7A)
 1.48A 5m66C-3g1uA:
56.6		 5m66C-3g1uA:
60.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M66_D_ADND502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
GLN A  56
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-3.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.51A 5m66D-3g1uA:
56.8		 5m66D-3g1uA:
60.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QGG_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 VAL A 217
VAL A 240
TYR A 256
GLN A 257
 None
 1.30A 5qggA-3g1uA:
undetectable		 5qggA-3g1uA:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QGO_A_ACTA302_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 VAL A 217
VAL A 240
TYR A 256
GLN A 257
 None
 1.32A 5qgoA-3g1uA:
undetectable		 5qgoA-3g1uA:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QGP_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 VAL A 217
VAL A 240
TYR A 256
GLN A 257
 None
 1.30A 5qgpA-3g1uA:
undetectable		 5qgpA-3g1uA:
19.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5UTU_F_ADNF503_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
THR A 156
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.54A 5utuF-3g1uA:
53.1		 5utuF-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5UTU_H_ADNH503_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		9 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.53A 5utuH-3g1uA:
51.1		 5utuH-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5UTU_H_ADNH503_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 5 THR A  57
GLU A 155
THR A 156
LEU A 343
 ADN  A 438 (-4.6A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
 0.64A 5utuH-3g1uA:
51.1		 5utuH-3g1uA:
50.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5V96_A_ADNA502_1
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.50A 5v96A-3g1uA:
56.4		 5v96A-3g1uA:
57.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5V96_B_ADNB502_1
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.49A 5v96B-3g1uA:
56.8		 5v96B-3g1uA:
57.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5V96_C_ADNC502_1
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.50A 5v96C-3g1uA:
56.8		 5v96C-3g1uA:
57.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5V96_D_ADND502_1
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.52A 5v96D-3g1uA:
56.7		 5v96D-3g1uA:
57.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X66_C_MTXC402_1
(THYMIDYLATE SYNTHASE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 9 ILE A 139
ASP A 129
LEU A 134
GLY A 132
ASN A 162
 None
 1.40A 5x66C-3g1uA:
undetectable		 5x66C-3g1uA:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XV7_A_EMHA705_2
(SERINE-ARGININE (SR)
PROTEIN KINASE 1)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 VAL A 365
LEU A 366
LEU A 391
ASP A 396
 None
 1.34A 5xv7A-3g1uA:
undetectable		 5xv7A-3g1uA:
11.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YNI_A_SAMA401_0
(NSP16 PROTEIN)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 GLY A 132
GLY A  49
ASN A 136
ASP A 133
ASP A 130
 None
None
None
None
ADN  A 438 (-4.1A)
 1.15A 5yniA-3g1uA:
2.9		 5yniA-3g1uA:
22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YNM_A_SAMA401_0
(NSP16 PROTEIN)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 GLY A 132
GLY A  49
ASN A 136
ASP A 133
ASP A 130
 None
None
None
None
ADN  A 438 (-4.1A)
 1.17A 5ynmA-3g1uA:
2.9		 5ynmA-3g1uA:
22.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6APH_A_ADNA501_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 343
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.49A 6aphA-3g1uA:
60.4		 6aphA-3g1uA:
64.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6APH_A_ADNA501_2
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 GLN A  56
THR A  57
THR A 156
HIS A 300
LEU A 346
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
 0.16A 6aphA-3g1uA:
60.4		 6aphA-3g1uA:
64.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EXI_A_ADNA502_0
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
GLN A  56
THR A  57
ASN A 345
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 (-3.1A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.18A 6exiA-3g1uA:
56.5		 6exiA-3g1uA:
71.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EXI_A_ADNA502_0
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		8 / 12 HIS A  52
THR A  54
GLN A  56
THR A  57
HIS A 300
LEU A 346
GLY A 351
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
None
 1.01A 6exiA-3g1uA:
56.5		 6exiA-3g1uA:
71.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EXI_A_ADNA503_0
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		8 / 10 GLY A 219
GLY A 221
GLU A 242
VAL A 243
ASP A 244
THR A 275
ASN A 277
ILE A 280
 NAD  A 439 (-3.5A)
NAD  A 439 (-3.5A)
NAD  A 439 (-2.9A)
NAD  A 439 (-4.1A)
None
NAD  A 439 (-4.0A)
NAD  A 439 ( 4.4A)
NAD  A 439 (-4.7A)
 0.32A 6exiA-3g1uA:
56.5		 6exiA-3g1uA:
71.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EXI_B_ADNB502_0
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		9 / 12 HIS A  52
THR A  54
GLN A  56
THR A  57
ASN A 345
LEU A 346
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 (-3.1A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.18A 6exiB-3g1uA:
53.6		 6exiB-3g1uA:
71.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EXI_B_ADNB502_0
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		7 / 12 HIS A  52
THR A  54
GLN A  56
THR A  57
HIS A 300
LEU A 346
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
None
 1.05A 6exiB-3g1uA:
53.6		 6exiB-3g1uA:
71.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EXI_B_ADNB503_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		8 / 10 GLY A 219
GLY A 221
GLU A 242
VAL A 243
ASP A 244
THR A 275
ASN A 277
ILE A 280
 NAD  A 439 (-3.5A)
NAD  A 439 (-3.5A)
NAD  A 439 (-2.9A)
NAD  A 439 (-4.1A)
None
NAD  A 439 (-4.0A)
NAD  A 439 ( 4.4A)
NAD  A 439 (-4.7A)
 0.35A 6exiB-3g1uA:
53.6		 6exiB-3g1uA:
71.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EXI_C_ADNC502_0
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  54
ASN A 190
LEU A 343
HIS A 352
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
NAD  A 439 (-3.2A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.6A)
 1.38A 6exiC-3g1uA:
54.1		 6exiC-3g1uA:
71.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EXI_C_ADNC502_0
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
GLN A  56
THR A  57
ASN A 190
ASN A 345
LEU A 346
HIS A 352
MET A 357
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 (-3.2A)
NAD  A 439 (-3.1A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
 0.51A 6exiC-3g1uA:
54.1		 6exiC-3g1uA:
71.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EXI_C_ADNC502_0
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		7 / 12 LEU A  51
HIS A  52
THR A  54
GLN A  56
THR A  57
HIS A 300
LEU A 346
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
 1.02A 6exiC-3g1uA:
54.1		 6exiC-3g1uA:
71.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EXI_C_ADNC502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		3 / 3 LEU A 343
GLY A 351
PHE A 361
 NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.8A)
None
 0.65A 6exiC-3g1uA:
54.1		 6exiC-3g1uA:
71.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EXI_C_ADNC503_0
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		8 / 12 GLY A 219
GLY A 221
GLU A 242
VAL A 243
ASP A 244
THR A 275
ASN A 277
ILE A 280
 NAD  A 439 (-3.5A)
NAD  A 439 (-3.5A)
NAD  A 439 (-2.9A)
NAD  A 439 (-4.1A)
None
NAD  A 439 (-4.0A)
NAD  A 439 ( 4.4A)
NAD  A 439 (-4.7A)
 0.36A 6exiC-3g1uA:
54.1
6exiD-3g1uA:
53.5		 6exiC-3g1uA:
71.62
6exiD-3g1uA:
71.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EXI_D_ADND502_0
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
GLN A  56
THR A  57
ASN A 345
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 (-3.1A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.25A 6exiD-3g1uA:
53.5		 6exiD-3g1uA:
71.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EXI_D_ADND502_0
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		8 / 12 HIS A  52
THR A  54
GLN A  56
THR A  57
HIS A 300
LEU A 346
GLY A 351
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
None
 1.05A 6exiD-3g1uA:
53.5		 6exiD-3g1uA:
71.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EXI_D_ADND503_0
(ADENOSYLHOMOCYSTEINA
SE)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		8 / 12 GLY A 219
GLY A 221
GLU A 242
VAL A 243
ASP A 244
THR A 275
ASN A 277
ILE A 280
 NAD  A 439 (-3.5A)
NAD  A 439 (-3.5A)
NAD  A 439 (-2.9A)
NAD  A 439 (-4.1A)
None
NAD  A 439 (-4.0A)
NAD  A 439 ( 4.4A)
NAD  A 439 (-4.7A)
 0.33A 6exiC-3g1uA:
54.1
6exiD-3g1uA:
53.5		 6exiC-3g1uA:
71.62
6exiD-3g1uA:
71.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3M_A_ADNA502_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
HIS A 300
LEU A 343
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.54A 6f3mA-3g1uA:
55.5		 6f3mA-3g1uA:
55.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3M_A_ADNA502_2
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 GLN A  56
THR A  57
THR A 156
LEU A 346
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.8A)
 0.12A 6f3mA-3g1uA:
55.5		 6f3mA-3g1uA:
55.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3M_B_ADNB502_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
HIS A 300
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.51A 6f3mB-3g1uA:
54.7		 6f3mB-3g1uA:
55.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3M_B_ADNB502_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
HIS A 300
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 (-3.7A)
 1.38A 6f3mB-3g1uA:
54.7		 6f3mB-3g1uA:
55.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3M_B_ADNB502_2
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 GLN A  56
THR A  57
THR A 156
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
 0.56A 6f3mB-3g1uA:
54.7		 6f3mB-3g1uA:
55.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3M_C_ADNC502_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
HIS A 300
LEU A 343
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.54A 6f3mC-3g1uA:
54.6		 6f3mC-3g1uA:
55.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3M_C_ADNC502_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
HIS A 300
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 (-3.7A)
 1.38A 6f3mC-3g1uA:
54.6		 6f3mC-3g1uA:
55.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3M_C_ADNC502_2
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 GLN A  56
THR A  57
THR A 156
LEU A 346
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.8A)
 0.13A 6f3mC-3g1uA:
54.6		 6f3mC-3g1uA:
55.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3M_D_ADND502_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
HIS A 300
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.52A 6f3mD-3g1uA:
54.7		 6f3mD-3g1uA:
55.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3M_D_ADND502_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 HIS A  52
THR A  57
ASP A 130
HIS A 300
MET A 357
 ADN  A 438 (-4.0A)
ADN  A 438 (-4.6A)
ADN  A 438 (-4.1A)
ADN  A 438 ( 4.0A)
ADN  A 438 (-3.7A)
 1.38A 6f3mD-3g1uA:
54.7		 6f3mD-3g1uA:
55.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3M_D_ADND502_2
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 5 GLN A  56
THR A  57
THR A 156
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
NAD  A 439 ( 4.0A)
 0.57A 6f3mD-3g1uA:
54.7		 6f3mD-3g1uA:
55.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3N_A_ADNA505_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 343
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.50A 6f3nA-3g1uA:
54.8		 6f3nA-3g1uA:
55.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3N_A_ADNA505_2
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 GLN A  56
THR A  57
THR A 156
HIS A 300
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
 0.17A 6f3nA-3g1uA:
54.8		 6f3nA-3g1uA:
55.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3N_B_ADNB505_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
THR A 156
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.51A 6f3nB-3g1uA:
55.0		 6f3nB-3g1uA:
55.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3N_B_ADNB505_2
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 GLN A  56
THR A  57
HIS A 300
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
 0.59A 6f3nB-3g1uA:
55.0		 6f3nB-3g1uA:
55.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3N_C_ADNC505_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 343
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.54A 6f3nC-3g1uA:
54.8		 6f3nC-3g1uA:
55.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3N_C_ADNC505_2
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 GLN A  56
THR A  57
THR A 156
HIS A 300
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
 0.17A 6f3nC-3g1uA:
54.8		 6f3nC-3g1uA:
55.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3N_D_ADND506_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 343
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.50A 6f3nD-3g1uA:
55.7		 6f3nD-3g1uA:
55.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6F3N_D_ADND506_2
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		4 / 4 GLN A  56
THR A  57
THR A 156
HIS A 300
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
 0.18A 6f3nD-3g1uA:
55.7		 6f3nD-3g1uA:
55.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6GBN_A_ADNA501_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.47A 6gbnA-3g1uA:
59.9		 6gbnA-3g1uA:
63.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6GBN_A_ADNA501_2
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 GLN A  56
THR A  57
THR A 156
HIS A 300
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
 0.60A 6gbnA-3g1uA:
59.9		 6gbnA-3g1uA:
63.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6GBN_B_ADNB501_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 343
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.55A 6gbnB-3g1uA:
62.2		 6gbnB-3g1uA:
63.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6GBN_B_ADNB501_2
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 GLN A  56
THR A  57
THR A 156
HIS A 300
LEU A 346
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 4.8A)
 0.19A 6gbnB-3g1uA:
62.2		 6gbnB-3g1uA:
63.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6GBN_C_ADNC501_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 LEU A  51
ASP A 130
GLU A 155
LEU A 343
HIS A 352
 None
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.6A)
 1.35A 6gbnC-3g1uA:
60.1		 6gbnC-3g1uA:
63.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6GBN_C_ADNC501_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 343
LEU A 346
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.56A 6gbnC-3g1uA:
60.1		 6gbnC-3g1uA:
63.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6GBN_C_ADNC501_2
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 GLN A  56
THR A  57
THR A 156
HIS A 300
GLY A 351
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
ADN  A 438 ( 3.8A)
 0.19A 6gbnC-3g1uA:
60.1		 6gbnC-3g1uA:
63.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6GBN_D_ADND501_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 12 LEU A  51
ASP A 130
GLU A 155
LEU A 343
HIS A 352
 None
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
NAD  A 439 ( 4.0A)
ADN  A 438 ( 3.6A)
 1.34A 6gbnD-3g1uA:
59.2		 6gbnD-3g1uA:
63.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6GBN_D_ADND501_1
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		10 / 12 LEU A  51
HIS A  52
THR A  54
ASP A 130
GLU A 155
LEU A 346
GLY A 351
HIS A 352
MET A 357
PHE A 361
 None
ADN  A 438 (-4.0A)
ADN  A 438 (-2.8A)
ADN  A 438 (-4.1A)
ADN  A 438 (-3.8A)
ADN  A 438 ( 4.8A)
ADN  A 438 ( 3.8A)
ADN  A 438 ( 3.6A)
ADN  A 438 (-3.7A)
None
 0.47A 6gbnD-3g1uA:
59.2		 6gbnD-3g1uA:
63.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6GBN_D_ADND501_2
(-)		 3g1u ADENOSYLHOMOCYSTEINA
SE
(Leishmania
major) 		5 / 5 GLN A  56
THR A  57
THR A 156
HIS A 300
LEU A 343
 ADN  A 438 (-3.8A)
ADN  A 438 (-4.6A)
NAD  A 439 ( 3.0A)
ADN  A 438 ( 4.0A)
NAD  A 439 ( 4.0A)
 0.59A 6gbnD-3g1uA:
59.2		 6gbnD-3g1uA:
63.88